OMNEXEL Tablet Prolonged Release 400 Microgram Ireland - English - HPRA (Health Products Regulatory Authority)

omnexel tablet prolonged release 400 microgram

mcdowell pharmaceuticals - tamsulosin hydrochloride - tablet prolonged release - 400 microgram

OMNEXEL Tablet Prolonged Release 400 Microgram Ireland - English - HPRA (Health Products Regulatory Authority)

omnexel tablet prolonged release 400 microgram

profind wholesale ltd. - tamsulosin hydrochloride - tablet prolonged release - 400 microgram

OMNEXEL Tablet Prolonged Release 400 Microgram Ireland - English - HPRA (Health Products Regulatory Authority)

omnexel tablet prolonged release 400 microgram

ltt pharma limited - tamsulosin hydrochloride - tablet prolonged release - 400 microgram

OMNEXEL Tablet Prolonged Release 400 Microgram Ireland - English - HPRA (Health Products Regulatory Authority)

omnexel tablet prolonged release 400 microgram

clear pharmacy - tamsulosin hydrochloride - tablet prolonged release - 400 microgram

OMSIL Capsules Modified Release 400 Microgram Ireland - English - HPRA (Health Products Regulatory Authority)

omsil capsules modified release 400 microgram

pliva pharma limited - tamsulosin hydrochloride - capsules modified release - 400 microgram

Hospira Vincristine Sulfate Injection USP 2 mg/2 mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

hospira vincristine sulfate injection usp 2 mg/2 ml vial

hospira australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection - excipient ingredients: water for injections; mannitol; sodium hydroxide; sulfuric acid - vincristine sulfate injection is indicated in acute leukemia. vincristine sulfate injection has also been shown to be useful in combination with other oncolytic agents in hodgkin's disease, non-hodgkin's malignant lymphomas (lymphocytic, mixed cell, histiocytic, undifferentiated, nodular and diffuse types), rhabdomyosarcoma, neuroblastoma, and wilm's tumor.

Brevinor-1 28 Day tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

brevinor-1 28 day tablet blister pack

pfizer australia pty ltd - ethinylestradiol, quantity: 36 microgram; norethisterone, quantity: 1 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; povidone; magnesium stearate - indications as at 31 august 1998 : contraception

Brevinor 28 Day tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

brevinor 28 day tablet blister pack

pfizer australia pty ltd - norethisterone, quantity: 500 microgram; ethinylestradiol, quantity: 36 microgram - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; lactose; sunset yellow fcf; lactose monohydrate - 31 august 1998 : contraception